 RESEARCH TRIANGLE PARK, N.C.--BUSINESS WIRE--Despite significant disruption and reprioritization of clinical trial activity during 2020 due to COVID-19, RD activity levels remained at historically high levels, driven by new funding and strategic transactions, especially within oncology, according to a new research report Global Trends in RD: Overview Through 2020 released by the IQVIATM Institute for Human Data Science. The growth in research and development driven by new oncology d 